Key Insights
The digital neurotherapeutics market is experiencing rapid growth, projected to reach $362.63 million in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 19.50% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of neurological and mental health disorders, coupled with the limitations of traditional therapeutic approaches, is driving demand for innovative, accessible, and effective digital solutions. Furthermore, advancements in technology, such as artificial intelligence (AI) and virtual reality (VR), are enabling the development of sophisticated digital therapeutics that offer personalized treatment plans and improved patient outcomes. The rising adoption of telehealth and remote patient monitoring further contributes to market growth, allowing for wider access to care, particularly in underserved areas. Strong industry support from both established pharmaceutical companies and innovative startups is also instrumental in driving market expansion. Competition is expected to intensify as more companies enter the market, leading to product diversification and price competition.
However, market growth is not without challenges. Regulatory hurdles and reimbursement complexities associated with new digital therapeutic devices represent significant obstacles. Ensuring data privacy and security is crucial to maintaining patient trust and addressing potential ethical concerns. Moreover, the effectiveness of digital therapeutics needs to be further validated through robust clinical trials to establish their efficacy and build widespread acceptance among healthcare professionals and patients. Overcoming these challenges will be vital for sustained market growth and ensuring the successful integration of digital neurotherapeutics into mainstream healthcare. The market's segmentation, while not explicitly provided, can reasonably be assumed to include categories based on the type of therapeutic application (e.g., depression, anxiety, cognitive impairment), the type of digital technology used (e.g., VR, AI, mobile apps), and the target patient population (e.g., adults, children).

Digital Neurotherapeutics Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Digital Neurotherapeutics Market, encompassing market dynamics, growth trends, regional analysis, product landscape, key players, and future outlook. The study period covers 2019-2033, with 2025 as the base and estimated year. The report offers invaluable insights for industry professionals, investors, and stakeholders seeking to understand and capitalize on the growth opportunities within this rapidly evolving sector. The parent market is the broader neurotherapeutics market, while the child market focuses specifically on digital solutions within this field. The market is expected to reach xx Million by 2033.
Digital Neurotherapeutics Market Dynamics & Structure
This section analyzes the market's competitive landscape, technological advancements, regulatory environment, and market trends. The market exhibits a moderately consolidated structure, with key players holding significant market share. However, the emergence of innovative startups is increasing competition.
- Market Concentration: The top 5 players hold an estimated 40% market share in 2025.
- Technological Innovation: Advancements in AI, VR/AR, and mobile technologies are driving innovation, enabling personalized and accessible treatments. However, data privacy and security remain significant barriers.
- Regulatory Frameworks: Varying regulatory approvals across different geographies impact market entry and product adoption. Streamlined regulatory processes are crucial for growth.
- Competitive Product Substitutes: Traditional neurotherapeutic methods compete with digital solutions, creating a need for establishing clinical efficacy and cost-effectiveness.
- End-User Demographics: The target demographics are expanding to include a wider age range and a broader spectrum of neurological conditions.
- M&A Trends: The number of M&A deals in the digital neurotherapeutics sector increased by 15% in 2024, indicating consolidation and strategic expansion.
Digital Neurotherapeutics Market Growth Trends & Insights
The digital neurotherapeutics market is experiencing significant growth, driven by increasing prevalence of neurological disorders, rising demand for accessible and cost-effective treatments, and technological advancements. The market size expanded from xx Million in 2019 to xx Million in 2024, and is projected to reach xx Million by 2033, exhibiting a CAGR of xx% during the forecast period. Adoption rates are increasing steadily, particularly in developed countries with robust healthcare infrastructure and technological adoption. Technological disruptions, such as AI-powered diagnostic tools and personalized treatment plans, are accelerating market growth. Consumer behavior shifts towards telehealth and remote monitoring solutions further fuel this expansion.

Dominant Regions, Countries, or Segments in Digital Neurotherapeutics Market
North America currently dominates the digital neurotherapeutics market, owing to high technological adoption, robust healthcare infrastructure, and significant investments in R&D. Europe and Asia-Pacific are also witnessing rapid growth, driven by increasing awareness of digital health solutions and rising prevalence of neurological disorders.
- North America: High healthcare expenditure, early adoption of new technologies, and a strong regulatory framework contribute to its market dominance.
- Europe: Growing investments in digital health initiatives and increasing prevalence of neurological conditions are driving market growth.
- Asia-Pacific: A large and growing population, rising healthcare expenditure, and increasing awareness of digital health solutions create significant growth potential.
Digital Neurotherapeutics Market Product Landscape
The market offers a diverse range of products, including mobile apps for cognitive training, virtual reality (VR) based therapies for rehabilitation, and AI-powered diagnostic tools. These products are designed to address various neurological conditions, ranging from stroke rehabilitation to cognitive impairment and mental health disorders. Key features include personalized treatment plans, remote monitoring capabilities, and integration with existing healthcare systems. The competitive edge often lies in the efficacy of the therapeutic intervention and the user experience.
Key Drivers, Barriers & Challenges in Digital Neurotherapeutics Market
Key Drivers:
- Increasing prevalence of neurological disorders
- Growing demand for accessible and affordable treatments
- Technological advancements in AI, VR/AR, and mobile technologies
- Favorable regulatory environment in certain regions
- Rising investments in digital health initiatives
Challenges:
- Data privacy and security concerns
- Reimbursement challenges and insurance coverage limitations
- Lack of standardization and clinical validation for some products
- High initial investment costs for technology development and implementation
- Competition from traditional neurotherapeutic methods
Emerging Opportunities in Digital Neurotherapeutics Market
- Expanding into untapped markets in developing countries.
- Development of new digital therapeutics for under-served neurological conditions.
- Integration of digital neurotherapeutics with wearable sensors and IoT devices.
- Personalized medicine approaches using AI and machine learning.
Growth Accelerators in the Digital Neurotherapeutics Market Industry
Strategic partnerships between technology companies and healthcare providers are driving market expansion. Technological breakthroughs in AI and machine learning are enabling more accurate diagnostics and personalized treatment plans. Expansion into new therapeutic areas and geographical markets is fueling long-term growth.
Key Players Shaping the Digital Neurotherapeutics Market Market
- Akili Inc
- AdvancedMD Inc
- AppliedVR Inc
- BigHealth
- Blackrock Neurotech
- Cognivive Inc
- Neofect Co Ltd
- Omada Health Inc
- Neurotherapeutic Pediatric Therapies Inc
- Mindmaze
Notable Milestones in Digital Neurotherapeutics Market Sector
- October 2023: MedRhythms' InTandem (MR-001) received prescription approval for at-home use in stroke rehabilitation.
- February 2024: The University of London launched the iTalkBetter app for aphasia treatment.
In-Depth Digital Neurotherapeutics Market Market Outlook
The digital neurotherapeutics market is poised for substantial growth, driven by continuous technological innovation and increasing adoption rates. Strategic partnerships, expansion into new markets, and the development of novel therapeutic applications will further fuel this expansion. The market presents significant opportunities for companies that can successfully navigate the regulatory landscape, address data privacy concerns, and demonstrate clinical efficacy.
Digital Neurotherapeutics Market Segmentation
-
1. Component
- 1.1. Software
- 1.2. Hardware
- 1.3. Services
-
2. Indication
- 2.1. Alzheimer’s Disease
- 2.2. Parkinson’s Disease
- 2.3. Multiple Sclerosis
- 2.4. Epilepsy
- 2.5. Other Indications
-
3. End User
- 3.1. Patients
- 3.2. Providers
- 3.3. Payers
- 3.4. Other End Users
Digital Neurotherapeutics Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Digital Neurotherapeutics Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 19.50% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Neurological Disorders; Growing Adoption of Digital Technology in Neurology Care
- 3.3. Market Restrains
- 3.3.1. Rising Prevalence of Neurological Disorders; Growing Adoption of Digital Technology in Neurology Care
- 3.4. Market Trends
- 3.4.1. The Multiple Sclerosis Segment is Expected to Hold Significant Market Share Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component
- 5.1.1. Software
- 5.1.2. Hardware
- 5.1.3. Services
- 5.2. Market Analysis, Insights and Forecast - by Indication
- 5.2.1. Alzheimer’s Disease
- 5.2.2. Parkinson’s Disease
- 5.2.3. Multiple Sclerosis
- 5.2.4. Epilepsy
- 5.2.5. Other Indications
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Patients
- 5.3.2. Providers
- 5.3.3. Payers
- 5.3.4. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Component
- 6. North America Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Component
- 6.1.1. Software
- 6.1.2. Hardware
- 6.1.3. Services
- 6.2. Market Analysis, Insights and Forecast - by Indication
- 6.2.1. Alzheimer’s Disease
- 6.2.2. Parkinson’s Disease
- 6.2.3. Multiple Sclerosis
- 6.2.4. Epilepsy
- 6.2.5. Other Indications
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Patients
- 6.3.2. Providers
- 6.3.3. Payers
- 6.3.4. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Component
- 7. Europe Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Component
- 7.1.1. Software
- 7.1.2. Hardware
- 7.1.3. Services
- 7.2. Market Analysis, Insights and Forecast - by Indication
- 7.2.1. Alzheimer’s Disease
- 7.2.2. Parkinson’s Disease
- 7.2.3. Multiple Sclerosis
- 7.2.4. Epilepsy
- 7.2.5. Other Indications
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Patients
- 7.3.2. Providers
- 7.3.3. Payers
- 7.3.4. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Component
- 8. Asia Pacific Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Component
- 8.1.1. Software
- 8.1.2. Hardware
- 8.1.3. Services
- 8.2. Market Analysis, Insights and Forecast - by Indication
- 8.2.1. Alzheimer’s Disease
- 8.2.2. Parkinson’s Disease
- 8.2.3. Multiple Sclerosis
- 8.2.4. Epilepsy
- 8.2.5. Other Indications
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Patients
- 8.3.2. Providers
- 8.3.3. Payers
- 8.3.4. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Component
- 9. Middle East and Africa Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Component
- 9.1.1. Software
- 9.1.2. Hardware
- 9.1.3. Services
- 9.2. Market Analysis, Insights and Forecast - by Indication
- 9.2.1. Alzheimer’s Disease
- 9.2.2. Parkinson’s Disease
- 9.2.3. Multiple Sclerosis
- 9.2.4. Epilepsy
- 9.2.5. Other Indications
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Patients
- 9.3.2. Providers
- 9.3.3. Payers
- 9.3.4. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Component
- 10. South America Digital Neurotherapeutics Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Component
- 10.1.1. Software
- 10.1.2. Hardware
- 10.1.3. Services
- 10.2. Market Analysis, Insights and Forecast - by Indication
- 10.2.1. Alzheimer’s Disease
- 10.2.2. Parkinson’s Disease
- 10.2.3. Multiple Sclerosis
- 10.2.4. Epilepsy
- 10.2.5. Other Indications
- 10.3. Market Analysis, Insights and Forecast - by End User
- 10.3.1. Patients
- 10.3.2. Providers
- 10.3.3. Payers
- 10.3.4. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Component
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Akili Inc
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 AdvancedMD Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 AppliedVR Inc
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 BigHealth
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Blackrock Neurotech
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Cognivive Inc
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Neofect Co Ltd
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Omada Health Inc
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Neurotherapeutic Pediatric Therapies Inc
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Mindmaze*List Not Exhaustive
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 Akili Inc
List of Figures
- Figure 1: Global Digital Neurotherapeutics Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Digital Neurotherapeutics Market Volume Breakdown (Million, %) by Region 2024 & 2032
- Figure 3: North America Digital Neurotherapeutics Market Revenue (Million), by Component 2024 & 2032
- Figure 4: North America Digital Neurotherapeutics Market Volume (Million), by Component 2024 & 2032
- Figure 5: North America Digital Neurotherapeutics Market Revenue Share (%), by Component 2024 & 2032
- Figure 6: North America Digital Neurotherapeutics Market Volume Share (%), by Component 2024 & 2032
- Figure 7: North America Digital Neurotherapeutics Market Revenue (Million), by Indication 2024 & 2032
- Figure 8: North America Digital Neurotherapeutics Market Volume (Million), by Indication 2024 & 2032
- Figure 9: North America Digital Neurotherapeutics Market Revenue Share (%), by Indication 2024 & 2032
- Figure 10: North America Digital Neurotherapeutics Market Volume Share (%), by Indication 2024 & 2032
- Figure 11: North America Digital Neurotherapeutics Market Revenue (Million), by End User 2024 & 2032
- Figure 12: North America Digital Neurotherapeutics Market Volume (Million), by End User 2024 & 2032
- Figure 13: North America Digital Neurotherapeutics Market Revenue Share (%), by End User 2024 & 2032
- Figure 14: North America Digital Neurotherapeutics Market Volume Share (%), by End User 2024 & 2032
- Figure 15: North America Digital Neurotherapeutics Market Revenue (Million), by Country 2024 & 2032
- Figure 16: North America Digital Neurotherapeutics Market Volume (Million), by Country 2024 & 2032
- Figure 17: North America Digital Neurotherapeutics Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: North America Digital Neurotherapeutics Market Volume Share (%), by Country 2024 & 2032
- Figure 19: Europe Digital Neurotherapeutics Market Revenue (Million), by Component 2024 & 2032
- Figure 20: Europe Digital Neurotherapeutics Market Volume (Million), by Component 2024 & 2032
- Figure 21: Europe Digital Neurotherapeutics Market Revenue Share (%), by Component 2024 & 2032
- Figure 22: Europe Digital Neurotherapeutics Market Volume Share (%), by Component 2024 & 2032
- Figure 23: Europe Digital Neurotherapeutics Market Revenue (Million), by Indication 2024 & 2032
- Figure 24: Europe Digital Neurotherapeutics Market Volume (Million), by Indication 2024 & 2032
- Figure 25: Europe Digital Neurotherapeutics Market Revenue Share (%), by Indication 2024 & 2032
- Figure 26: Europe Digital Neurotherapeutics Market Volume Share (%), by Indication 2024 & 2032
- Figure 27: Europe Digital Neurotherapeutics Market Revenue (Million), by End User 2024 & 2032
- Figure 28: Europe Digital Neurotherapeutics Market Volume (Million), by End User 2024 & 2032
- Figure 29: Europe Digital Neurotherapeutics Market Revenue Share (%), by End User 2024 & 2032
- Figure 30: Europe Digital Neurotherapeutics Market Volume Share (%), by End User 2024 & 2032
- Figure 31: Europe Digital Neurotherapeutics Market Revenue (Million), by Country 2024 & 2032
- Figure 32: Europe Digital Neurotherapeutics Market Volume (Million), by Country 2024 & 2032
- Figure 33: Europe Digital Neurotherapeutics Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: Europe Digital Neurotherapeutics Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Asia Pacific Digital Neurotherapeutics Market Revenue (Million), by Component 2024 & 2032
- Figure 36: Asia Pacific Digital Neurotherapeutics Market Volume (Million), by Component 2024 & 2032
- Figure 37: Asia Pacific Digital Neurotherapeutics Market Revenue Share (%), by Component 2024 & 2032
- Figure 38: Asia Pacific Digital Neurotherapeutics Market Volume Share (%), by Component 2024 & 2032
- Figure 39: Asia Pacific Digital Neurotherapeutics Market Revenue (Million), by Indication 2024 & 2032
- Figure 40: Asia Pacific Digital Neurotherapeutics Market Volume (Million), by Indication 2024 & 2032
- Figure 41: Asia Pacific Digital Neurotherapeutics Market Revenue Share (%), by Indication 2024 & 2032
- Figure 42: Asia Pacific Digital Neurotherapeutics Market Volume Share (%), by Indication 2024 & 2032
- Figure 43: Asia Pacific Digital Neurotherapeutics Market Revenue (Million), by End User 2024 & 2032
- Figure 44: Asia Pacific Digital Neurotherapeutics Market Volume (Million), by End User 2024 & 2032
- Figure 45: Asia Pacific Digital Neurotherapeutics Market Revenue Share (%), by End User 2024 & 2032
- Figure 46: Asia Pacific Digital Neurotherapeutics Market Volume Share (%), by End User 2024 & 2032
- Figure 47: Asia Pacific Digital Neurotherapeutics Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Asia Pacific Digital Neurotherapeutics Market Volume (Million), by Country 2024 & 2032
- Figure 49: Asia Pacific Digital Neurotherapeutics Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Asia Pacific Digital Neurotherapeutics Market Volume Share (%), by Country 2024 & 2032
- Figure 51: Middle East and Africa Digital Neurotherapeutics Market Revenue (Million), by Component 2024 & 2032
- Figure 52: Middle East and Africa Digital Neurotherapeutics Market Volume (Million), by Component 2024 & 2032
- Figure 53: Middle East and Africa Digital Neurotherapeutics Market Revenue Share (%), by Component 2024 & 2032
- Figure 54: Middle East and Africa Digital Neurotherapeutics Market Volume Share (%), by Component 2024 & 2032
- Figure 55: Middle East and Africa Digital Neurotherapeutics Market Revenue (Million), by Indication 2024 & 2032
- Figure 56: Middle East and Africa Digital Neurotherapeutics Market Volume (Million), by Indication 2024 & 2032
- Figure 57: Middle East and Africa Digital Neurotherapeutics Market Revenue Share (%), by Indication 2024 & 2032
- Figure 58: Middle East and Africa Digital Neurotherapeutics Market Volume Share (%), by Indication 2024 & 2032
- Figure 59: Middle East and Africa Digital Neurotherapeutics Market Revenue (Million), by End User 2024 & 2032
- Figure 60: Middle East and Africa Digital Neurotherapeutics Market Volume (Million), by End User 2024 & 2032
- Figure 61: Middle East and Africa Digital Neurotherapeutics Market Revenue Share (%), by End User 2024 & 2032
- Figure 62: Middle East and Africa Digital Neurotherapeutics Market Volume Share (%), by End User 2024 & 2032
- Figure 63: Middle East and Africa Digital Neurotherapeutics Market Revenue (Million), by Country 2024 & 2032
- Figure 64: Middle East and Africa Digital Neurotherapeutics Market Volume (Million), by Country 2024 & 2032
- Figure 65: Middle East and Africa Digital Neurotherapeutics Market Revenue Share (%), by Country 2024 & 2032
- Figure 66: Middle East and Africa Digital Neurotherapeutics Market Volume Share (%), by Country 2024 & 2032
- Figure 67: South America Digital Neurotherapeutics Market Revenue (Million), by Component 2024 & 2032
- Figure 68: South America Digital Neurotherapeutics Market Volume (Million), by Component 2024 & 2032
- Figure 69: South America Digital Neurotherapeutics Market Revenue Share (%), by Component 2024 & 2032
- Figure 70: South America Digital Neurotherapeutics Market Volume Share (%), by Component 2024 & 2032
- Figure 71: South America Digital Neurotherapeutics Market Revenue (Million), by Indication 2024 & 2032
- Figure 72: South America Digital Neurotherapeutics Market Volume (Million), by Indication 2024 & 2032
- Figure 73: South America Digital Neurotherapeutics Market Revenue Share (%), by Indication 2024 & 2032
- Figure 74: South America Digital Neurotherapeutics Market Volume Share (%), by Indication 2024 & 2032
- Figure 75: South America Digital Neurotherapeutics Market Revenue (Million), by End User 2024 & 2032
- Figure 76: South America Digital Neurotherapeutics Market Volume (Million), by End User 2024 & 2032
- Figure 77: South America Digital Neurotherapeutics Market Revenue Share (%), by End User 2024 & 2032
- Figure 78: South America Digital Neurotherapeutics Market Volume Share (%), by End User 2024 & 2032
- Figure 79: South America Digital Neurotherapeutics Market Revenue (Million), by Country 2024 & 2032
- Figure 80: South America Digital Neurotherapeutics Market Volume (Million), by Country 2024 & 2032
- Figure 81: South America Digital Neurotherapeutics Market Revenue Share (%), by Country 2024 & 2032
- Figure 82: South America Digital Neurotherapeutics Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Digital Neurotherapeutics Market Volume Million Forecast, by Region 2019 & 2032
- Table 3: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 4: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 5: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 6: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 7: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 8: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 9: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Global Digital Neurotherapeutics Market Volume Million Forecast, by Region 2019 & 2032
- Table 11: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 12: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 13: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 14: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 15: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 16: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 17: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Digital Neurotherapeutics Market Volume Million Forecast, by Country 2019 & 2032
- Table 19: United States Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United States Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 21: Canada Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Canada Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 23: Mexico Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Mexico Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 25: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 26: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 27: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 28: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 29: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 30: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 31: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Digital Neurotherapeutics Market Volume Million Forecast, by Country 2019 & 2032
- Table 33: Germany Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Germany Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 35: United Kingdom Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: United Kingdom Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 37: France Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: France Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 39: Italy Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Italy Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 41: Spain Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Spain Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 43: Rest of Europe Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Europe Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 45: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 46: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 47: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 48: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 49: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 50: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 51: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Digital Neurotherapeutics Market Volume Million Forecast, by Country 2019 & 2032
- Table 53: China Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: China Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 55: Japan Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Japan Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 57: India Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: India Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 59: Australia Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Australia Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 61: South Korea Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: South Korea Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 63: Rest of Asia Pacific Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: Rest of Asia Pacific Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 65: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 66: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 67: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 68: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 69: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 70: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 71: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Digital Neurotherapeutics Market Volume Million Forecast, by Country 2019 & 2032
- Table 73: GCC Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: GCC Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 75: South Africa Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: South Africa Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 77: Rest of Middle East and Africa Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: Rest of Middle East and Africa Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 79: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Component 2019 & 2032
- Table 80: Global Digital Neurotherapeutics Market Volume Million Forecast, by Component 2019 & 2032
- Table 81: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 82: Global Digital Neurotherapeutics Market Volume Million Forecast, by Indication 2019 & 2032
- Table 83: Global Digital Neurotherapeutics Market Revenue Million Forecast, by End User 2019 & 2032
- Table 84: Global Digital Neurotherapeutics Market Volume Million Forecast, by End User 2019 & 2032
- Table 85: Global Digital Neurotherapeutics Market Revenue Million Forecast, by Country 2019 & 2032
- Table 86: Global Digital Neurotherapeutics Market Volume Million Forecast, by Country 2019 & 2032
- Table 87: Brazil Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Brazil Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 89: Argentina Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: Argentina Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
- Table 91: Rest of South America Digital Neurotherapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: Rest of South America Digital Neurotherapeutics Market Volume (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Digital Neurotherapeutics Market?
The projected CAGR is approximately 19.50%.
2. Which companies are prominent players in the Digital Neurotherapeutics Market?
Key companies in the market include Akili Inc, AdvancedMD Inc, AppliedVR Inc, BigHealth, Blackrock Neurotech, Cognivive Inc, Neofect Co Ltd, Omada Health Inc, Neurotherapeutic Pediatric Therapies Inc, Mindmaze*List Not Exhaustive.
3. What are the main segments of the Digital Neurotherapeutics Market?
The market segments include Component, Indication, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 362.63 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Neurological Disorders; Growing Adoption of Digital Technology in Neurology Care.
6. What are the notable trends driving market growth?
The Multiple Sclerosis Segment is Expected to Hold Significant Market Share Over the Forecast Period.
7. Are there any restraints impacting market growth?
Rising Prevalence of Neurological Disorders; Growing Adoption of Digital Technology in Neurology Care.
8. Can you provide examples of recent developments in the market?
February 2024: The University of London's neurotherapeutics group launched the iTalkBetter app. This app provides speech therapy for people with language disorder aphasia, which has been found to improve their ability to talk significantly.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Digital Neurotherapeutics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Digital Neurotherapeutics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Digital Neurotherapeutics Market?
To stay informed about further developments, trends, and reports in the Digital Neurotherapeutics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence